Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T18:57:44.474Z.
Calculation as of: 2026-10-06T18:57:44.474Z.
Quote observation: 2026-10-06T18:55:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 270619a8cb927235a94e92f97c71cdfb8fe28fc97d8c39ede642bd89729a24e3
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Mobile-health Network Solutions Class A Ordinary Shares
Market Cap
$30263.00
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6001.00
PS Ratio
N/A
TTM Avg
7806.34
3Y Avg
7806.34
5Y Avg
7806.34
Market Cap
$70876.00
PS Ratio
1.79
TTM Avg
236.43
3Y Avg
15964481498759.19
5Y Avg
12825398057992.62
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | $30263.00 | N/A | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | N/A | N/A | N/A | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $6001.00 | N/A | 7806.34 | 7806.34 | 7806.34 |
| Akanda Corp. (AKAN)vs › | $61819.00 | N/A | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | 1.79 | 236.43 | 15964481498759.19 | 12825398057992.62 |
| Psyence Biomedical Ltd. (PBM)vs › | $96215.00 | N/A | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $108771.00 | N/A | N/A | N/A | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $352721.00 | N/A | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A | N/A | N/A | N/A |
Half-year reporter: no trailing two-half-year basis, because the newest half-year ended more than 270 days before this quote.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
